Diez cosas que debes conocer sobre el uso de fármacos de cesación tabáquica

Banks et al. Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence. BMC Medicine (2015) 13:38. DOI 10.1186/s12916-015-0281-z. Disponible en: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0281-z.

Moore RA, Aubin HJ. Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions? Int. J. Environ. Res. Public Health 2012. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315081/pdf/ijerph-09-00192.pdf.

Egüés Olazabal Nerea, Delfrade Osinaga Iosu, Dominguez Pascual Sonia y cols. Programa de ayuda para dejar de fumar en Navarra. 25 años de andadura. Rev Esp Salud Pública. 2019; Vol. 93; 15 de julio 201907039.e1-e8. Disponible en: https://www.mscbs.gob.es/biblioPublic/publicaciones/recursos_propios/resp/revista_cdrom/VOL93/C_ESPECIALES/RS93C_201907039.pdf.

Salguero Chaves Emilio, Ávila García Raúl, Peinado Reina Marta y cols. Unidad-Escuela de Estilos de Vida Saludables en un centro de salud de Badajoz: evaluación 2007-2017. Comunidad Noviembre 2019;21(3):7
ISSN: 2339-7896. Disponible en: https://comunidadsemfyc.es/unidad-escuela-de-estilos-de-vida-saludables-en-un-centro-de-salud-de-badajoz-evaluacion-2007-2017/

Cornuz J, Gilbert A, Pinget C et al. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison. Tobacco Control 2006; 15:152-159.

Córdoba R, et al. Recomendaciones sobre el estilo de vida. Actualizacón PAPPS 2018. Aten. Primaria 2018;50(Supl 1):29-40

Treating Tobacco Use and Dependence: 2008 Update – NCBI Bookshelf [Internet].. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK63952/

Martin Cantera, et al. Effectiveness of multicomponent interventions in primary healthcare settings to promote continuous smoking cessation in adults: a systematic review.BMJ Open 2015 ;5: e008807. doi: 10.1136/bmjopen-2015-008807

Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016:CD006103.

Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. En: The Cochrane Collaboration, Cahill K, editors. Cochrane Database Syst. Rev., Chichester, UK: John Wiley & Sons, Ltd; 2013.

Smith PH, Weinberger AH, Zhang J, Emme E, Mazure CM, McKee SA. Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis. Nicotine Tob Res. 2016: ntw144.

Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2019; 4: CD013308-CD013308

Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014; 1: CD000031.

Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet Lond Engl. 2016; 387: 2507-20.

Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). Ficha técnica de Zyntabac 150 mg, comprimidos de liberación prolongada. Disponible en: https://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2001/docs/bupropion_FT.pdf.

Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). Ficha técnica de vareniclina 0,5 mg. https://cima.aemps.es/cima/dochtml/ft/06360001/FT_06360001.html

Cahill K. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Systematic Reviews 2012.

Farley AC, Hajek P, Lycett F, Aveyrad P. Interventions for preventing weight gain alter smoking cessation (Review). Cochrane Database of Systematic Reviews 2012, Jan 8; 1:CD006219.doi:10.1002/14651858. Disponible en: https://www.cochrane.org/CD006219/TOBACCO_interventions-for-preventing-weight-gain-after-smoking-cessation

Escaffi MJ, Cuevas A, Vergara K, Alonso R, Tabaco y peso corporal. Rev. Chil Enferm Respir 2017; 33: 249-251. Disponible en: https://scielo.conicyt.cl/pdf/rcher/v33n3/0717-7348-rcher-33-03-0249.pdf

Hollands GJ, McDermott MS, Lindson-Hawley N, Vogt F, Farley A, Aveyard P. Interventions to increase adherence to medications for tobacco dependence. Cochrane Database Syst Rev. 2015; (2):CD009164.

Salvador M, Ayesta FJ. La adherencia terapéutica en el tabaquismo. Intervención Psicosocial 2009; 18:233-44